CO4940489A1 - Nuevo metodo de tratamiento cines asociadas a la misma en mamiferos - Google Patents

Nuevo metodo de tratamiento cines asociadas a la misma en mamiferos

Info

Publication number
CO4940489A1
CO4940489A1 CO98040749A CO98040749A CO4940489A1 CO 4940489 A1 CO4940489 A1 CO 4940489A1 CO 98040749 A CO98040749 A CO 98040749A CO 98040749 A CO98040749 A CO 98040749A CO 4940489 A1 CO4940489 A1 CO 4940489A1
Authority
CO
Colombia
Prior art keywords
treatment
thiazolidin
dione
benzyl
cinema
Prior art date
Application number
CO98040749A
Other languages
English (en)
Spanish (es)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CO4940489A1 publication Critical patent/CO4940489A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
CO98040749A 1997-07-18 1998-07-17 Nuevo metodo de tratamiento cines asociadas a la misma en mamiferos CO4940489A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
CO4940489A1 true CO4940489A1 (es) 2000-07-24

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98040749A CO4940489A1 (es) 1997-07-18 1998-07-17 Nuevo metodo de tratamiento cines asociadas a la misma en mamiferos

Country Status (27)

Country Link
EP (1) EP1001784A1 (sk)
JP (1) JP2001510160A (sk)
KR (1) KR20010021952A (sk)
CN (1) CN1263467A (sk)
AP (1) AP2000001735A0 (sk)
AR (2) AR016350A1 (sk)
AU (1) AU8449098A (sk)
BG (1) BG104062A (sk)
BR (1) BR9810292A (sk)
CA (1) CA2297133A1 (sk)
CO (1) CO4940489A1 (sk)
DZ (1) DZ2563A1 (sk)
EA (1) EA200000140A1 (sk)
GB (1) GB9715298D0 (sk)
HU (1) HUP0003626A3 (sk)
ID (1) ID23804A (sk)
IL (1) IL133907A0 (sk)
MA (1) MA24608A1 (sk)
NO (1) NO20000230L (sk)
OA (1) OA11312A (sk)
PE (1) PE99499A1 (sk)
PL (1) PL338140A1 (sk)
SK (1) SK612000A3 (sk)
TR (1) TR200000133T2 (sk)
UY (1) UY25101A1 (sk)
WO (1) WO1999003478A1 (sk)
ZA (1) ZA986364B (sk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
AU5325200A (en) 1999-06-21 2001-01-09 Eli Lilly And Company Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes
JP2003520226A (ja) * 2000-01-21 2003-07-02 ノバルティス アクチエンゲゼルシャフト ジペプチジルペプチダーゼ−ｉｖ阻害剤および抗糖尿病薬剤を含む組合せ物
CA2401356A1 (en) * 2000-02-24 2001-08-30 Takeda Chemical Industries, Ltd. Combination drug
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
AU2004285354B2 (en) 2003-10-31 2009-09-17 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0601001B1 (en) * 1991-08-26 1997-04-16 PHARMACIA & UPJOHN COMPANY Liquid food product containing 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
BG104062A (en) 2000-11-30
TR200000133T2 (tr) 2000-09-21
OA11312A (en) 2003-10-24
WO1999003478A1 (en) 1999-01-28
NO20000230D0 (no) 2000-01-17
EP1001784A1 (en) 2000-05-24
HUP0003626A2 (hu) 2001-05-28
BR9810292A (pt) 2000-09-19
DZ2563A1 (fr) 2003-02-15
JP2001510160A (ja) 2001-07-31
ZA986364B (en) 2000-01-17
AR019724A2 (es) 2002-03-13
PL338140A1 (en) 2000-09-25
AP2000001735A0 (en) 2000-01-16
HUP0003626A3 (en) 2001-12-28
KR20010021952A (ko) 2001-03-15
UY25101A1 (es) 2000-12-29
GB9715298D0 (en) 1997-09-24
MA24608A1 (fr) 1999-04-01
SK612000A3 (en) 2000-07-11
IL133907A0 (en) 2001-04-30
PE99499A1 (es) 1999-12-18
EA200000140A1 (ru) 2000-06-26
CA2297133A1 (en) 1999-01-28
NO20000230L (no) 2000-01-17
AR016350A1 (es) 2001-07-04
AU8449098A (en) 1999-02-10
ID23804A (id) 2000-05-11
CN1263467A (zh) 2000-08-16

Similar Documents

Publication Publication Date Title
CO5300392A1 (es) Nueva composicion y uso
MY129897A (en) Use of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2, 4-dione and metformin for the treatment of diabetes mellitus
HUP0003876A2 (hu) Tiazolidin-dion-származékok alkalmazása polycystás petefészek szindróma és terhességi diabetes kezelésére
CO4940420A1 (es) Nuevo metodo de tratamiento
CO4940489A1 (es) Nuevo metodo de tratamiento cines asociadas a la misma en mamiferos
EP1593379A3 (en) Uses of PPAR-gamma agonists in neutrophil-induced diseases
NO2963A (no) Anvendelse av forbindelsen 5-[4-[2-(5-etylpyridin-2-yl)- etoksy]benzyl]tiazolidin-2,4-dion (pioglitazone) for fremstilling av et medikament for behandling av svekket glukosetoleranse
CO4940422A1 (es) Novedoso metodo de tratamiento
WO2000076488A3 (en) Use of a ppar agonist for treating type 1 diabetes
US5708012A (en) Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
PE20001428A1 (es) Composicion de liberacion modificada
AR015894A1 (es) Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona e insulina para la preparacion de un medicamento y composicion farmaceuticaque contiene dichos compuestos
NZ513922A (en) Composition comprising 5-Ä4-Ä2-(N-methyl-N-2-pyridyl)-amino)ethoxy!benzyl!thiazolidine-2-4-dione
AP1600A (en) Combination of a thiazolidinedione and a sulphonylurea for treating diabetes
PE20001239A1 (es) Composicion de un sensibilizador de insulina
NZ522730A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
BR0112982A (pt) Sal tartarato de derivado de tiazolidinadiona
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
DK1315724T3 (da) Thiazolidindionderivat og dets anvendelse som antidiabetikum
PE20000881A1 (es) Uso de tiazolidindiona como cardioprotector
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
MXPA02012619A (es) Tratamiento y prevencion de condiciones asociadas con resistencia a la insulina cardiaca.
HUP0003673A2 (hu) Dioxo-tiazolidinek alkalmazása a hyperglykaemia kezelésére
AU2000254153A1 (en) Treatment and prevention of cardiac insulin resistance associated conditions
HRP20000255A2 (en) Use of thiazolidinediones for the treatment of hyperglycaemia